Eli Lilly shares rise over 7% pre-market after Q3 results exceed estimates and FY revenue outlook raised

Thursday, Oct 30, 2025 6:46 am ET1min read

Eli Lilly shares rise over 7% pre-market after Q3 results exceed estimates and FY revenue outlook raised

Comments



Add a public comment...
No comments

No comments yet